Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 59 | Issue 3s | 2025 | pp. s1163–s1174Open access
Potentially Inappropriate Psychotropic Drug Prescriptions and Polypharmacy among Geriatric Home Healthcare Patients: A Cross-Sectional Study
- 1*,
- 1
- 1 Department of Psychiatry, Republic of Turkey Ministry of Health, Yalvac State Hospital, Isparta, TÜRKIYE.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Selin Tanyeri Kayahan
Department of Psychiatry, Republic of Turkey Ministry of Health, Yalvac State Hospital, Isparta, TÜRKIYE.
Email: selintanyeri@yahoo.com.tr
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Dec 28, 2023
- Accepted:
- Apr 2, 2025
- DOI:
- 10.5530/ijper.20256020
How to cite
Kayahan, S. T., & Kayahan, A. (2025). Potentially Inappropriate Psychotropic Drug Prescriptions and Polypharmacy among Geriatric Home Healthcare Patients: A Cross-Sectional Study. Indian Journal of Pharmaceutical Education and Research, 59(3s), s1163–s1174. https://doi.org/10.5530/ijper.20256020
Abstract
Introduction
Comorbidities, psychotropic drug use and polypharmacy are common in elderly individuals. Research evaluating the psychotropic drug prescriptions among geriatric patients in a homecare health setting is limited. This study aimed to examine the medications of geriatric home healthcare patients regarding psychotropic drugs and polypharmacy and to assess their potential inappropriateness.
Materials and Methods
Sociodemographic, clinical, drug prescription and home health service-specific data of patients who were 65 or older and registered in a home healthcare unit were collected from the electronic files. Comorbidities were scored according to the Charlson Comorbidity Index and the safety of psychotropic drugs was evaluated with the 2023 version of the American Geriatric Society’s Beers Criteria.
Results
Of the 229 patients included, 69.9% (n=160) were women and the mean age was 83±7.97. 2 out of every 3 patients were considered severely ill. Polypharmacy was 78.6% (n=180) and at least 1 psychotropic drug was prescribed for half of the sample. The average of prescribed psychotropic drugs was 2.01±1.18 and potentially inappropriate psychotropic drug prescriptions were 46% (n=52). The most frequently prescribed antidepressants and antipsychotic were escitalopram (50.7%) and quetiapine (65.3%). Polypharmacy and psychotropic drug prescriptions were associated with age (OR: 0.93, 95% CI: 0.89-0.97, p=.004; OR:4.13, 95% CI:1.03-16.59, p=.045) while potentially inappropriate psychotropic drug prescriptions were associated with antipsychotic medication (OR:15.90, 95% CI:3.46-72.96, p<.001).
Conclusion
Potentially inappropriate psychotropic medication seems frequent among geriatric patients. Considering the aging population, it will be of great importance for clinicians and pharmacists to carefully evaluate psychotropic prescriptions and polypharmacy.
Keywords
Subject
Article metadata
| Title | Potentially Inappropriate Psychotropic Drug Prescriptions and Polypharmacy among Geriatric Home Healthcare Patients: A Cross-Sectional Study |
|---|---|
| Authors | Selin Tanyeri Kayahan; Ali Kayahan |
| Affiliations | Department of Psychiatry, Republic of Turkey Ministry of Health, Yalvac State Hospital, Isparta, TÜRKIYE. |
| Corresponding author | selintanyeri@yahoo.com.tr |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 59, Issue 3s (2025) |
Also in this issue
- Mesoporous Silica Nanoparticles: A Promising Portal for Diagnosis and Treatment for Chronic Diseasespp. s776–s787
- Nanostructured Lipid Carrier to Improve Oral Bioavailabilitypp. s788–s801
- A Review on Preparation Methods of Drug Loading Solid Lipid Nanoparticles with the Application in various Cancer Treatmentpp. s802–s813
- A Comprehensive Review on Management of Insulin Resistance Disorder by Innovative Technologies and Advancement of Precision Medicinal Therapiespp. s814–s824
- Formulation and Evaluation of Orally Disintegrating Tablet Containing Aripiprazole in the Context of Quality by Design Approachpp. s825–s836